Home - Products - Others - Other Targets - Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside

Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside

CAS No. 185044-11-5

Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside( ——— )

Catalog No. M39760 CAS No. 185044-11-5

Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside
  • Description
    Cyanidin-3-O-[6-O-trans-caffeyl-(6-O-p-hydroxybenzoyl-2-O-β-glucopyranosyl)]-β-glucopyranoside)-5-O-β-glucopyranoside
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    185044-11-5
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MM 54

    Potent apelin receptor antagonist (Ki = 82 nM; IC50 = 93 nM). Antagonizes the inhibitory affect of [Pyr1]-Apelin-13 on forskolin-induced cAMP accumulation in CHO-K1-APJ cells. Recuces tumor expansion and lengthens survival time in a mouse xenograft model of glioblastoma.

  • α-Conotoxin RgIA

    α-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. α-Conotoxin RgIA can be obtained from Conus regius venom. α-Conotoxin RgIA can be used in the study of neurological diseases.

  • pep2-SVKI

    Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluA2 AMPA receptor subunit. Disrupts binding of GluA2 (at the C-terminal PDZ site) with glutamate receptor interacting protein (GRIP), AMPA receptor binding protein (ABP) and protein interacting with C kinase (PICK1). Increases amplitude of AMPA receptor-mediated currents and blocks long-term depression (LTD).